Products Categories
CAS No.: | 518-94-5 |
---|---|
Name: | CYCLEANINE |
Article Data: | 11 |
Molecular Structure: | |
Formula: | C38H42 N2 O6 |
Molecular Weight: | 622.761 |
Synonyms: | Cycleanine(6CI,7CI,8CI); (-)-Cycleanine;8,11:20,23-Dietheno-1H,12H-[1,10]dioxacyclooctadecino[2,3,4-ij:11,12,13-i'j']diisoquinoline,2,3,12a,13,14,15,24,24a-octahydro-5,6,17,18-tetramethoxy-1,13-dimethyl-,[12aR-(12aR*,24aR*)]-; Alkaloid B, from Cissampelos pareira;Dimethylisochondodendrine; O,O-Dimethylisochondodendrin;O,O-Dimethylisochondrodendrine; O,O'-Dimethylisochondrodendrine;O-Methylnorcycleanine;[12aR-(12aR*,24aR*)]-2,3,12a,13,14,15,24,24a-Octahydro-5,6,17,18-tetramethoxy-1,13-dimethyl-8,11:20,23-dietheno-1H,12H-[1,10]dioxacyclooctadecino[2,3,4-ij:11,12,13-i'j']diisoquinoline |
Density: | 1.172g/cm3 |
Melting Point: | 272-273 °C |
Boiling Point: | 691.6°Cat760mmHg |
Flash Point: | 169.8°C |
PSA: | 61.86000 |
LogP: | 7.03820 |
Molecular Structure of Cycleanine (CAS NO.518-94-5):
Molecular Formula: C38H42N2O6
Molecular Weight: 622.7499
IUPAC Name: (4-Benzoyl-3-hydroxyphenyl) 2-methylprop-2-enoate
Synonyms of Cycleanine (CAS NO.518-94-5): (-)-Cycleanine ; Dimethylisochondodendrine ; O,O-Dimethylisochondodendrin ; O,O-Dimethylisochondrodendrine ; O-Methylnorcycleanine ; 8,11:20,23-Dietheno-1H,12H-(1,10)dioxacyclooctadecino(2,3,4-ij:11,12,13-i'j')diisoquinoline, 2,3,12a,13,14,15,24,24a-octahydro-1,13-dimethyl-5,6,17,18-tetramethoxy-, (12aR-(12aR*,24aR*))- ; Cycleanine (6CI,7CI,8CI)
CAS NO: 518-94-5
Product Categories: Drug / Therapeutic Agent ; Natural Product
Index of Refraction: 1.585
Molar Refractivity: 178.12 cm3
Molar Volume: 531.1 cm3
Surface Tension: 41.7 dyne/cm
Density: 1.172 g/cm3
Flash Point: 169.8 °C
Enthalpy of Vaporization: 101.34 kJ/mol
Boiling Point: 691.6 °C at 760 mmHg
Vapour Pressure of Cycleanine (CAS NO.518-94-5): 5.62E-19 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 1010mg/kg (1010mg/kg) | Indian Journal of Pharmacology. Vol. 29, Pg. S366, 1997. |